Maravai Lifesciences Holdings Inc (MRVI)

Maravai Lifesciences Holdings, Inc. is a San Diego-based life sciences company founded in 2014 and listed on NASDAQ under the ticker MRVI. The company develops products that support drug therapy, vaccine, cell and gene therapy, and diagnostic development across North America, Europe, the Middle East, Africa, Asia Pacific, and Latin and Central America. Its operations are organized into two segments: TRILINK and CYGNUS. TRILINK focuses on products used in gene therapy, nucleoside chemistry, oligonucleotide therapy, molecular diagnostics, and related research, including reagents for DNA and RNA synthesis, modification, labeling, and purification, along with messenger RNA, oligonucleotides, CleanCap-based building blocks, custom enzyme development, and protein labeling and detection products. CYGNUS provides analytical products and custom services for biologic manufacturing development, including antibody and assay development, ELISA kits, ancillary reagents, viral clearance prediction kits, and impurity and contaminant testing tools.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.